Clinical Trial for Evaluation of Ethnic Differences in Pharmacokinetics of Chloroquine, an Anti-malarial Drug
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
Chloroquine is an anti-malaria agent. This study is designed to evaluate inter-ethnic
differences of therapeutic effect of chloroquine and search the cause of these ethnic
differences. For this purpose, chloroquine will be administered to four ethic groups of
Korean, Caucasian, African and Southeast Asian and chloroquine concentration in blood will be
measured. The result of this study will be helpful in finding more adequate dosing regimen of
chloroquine in patients with malaria.